Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Compugen Ltd (CGEN)

https://www.cgen.com

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/11/2000

Market Cap

162,956,248

Shares Outstanding

88,330,000

Weighted SO

88,327,207

Total Employees

N/A

Upcoming Earnings

08/05/2024

Similar Tickers

PHGE --.--%

PLUR --.--%

SURF --.--%

BLRX --.--%

ITOS --.--%

ICVX --.--%

MRTX --.--%

VECT --.--%

ANNX --.--%

Beta

2.6010

Last Div

0.0000

Range

0.53-3.03

Chg

0.0100

Avg Vol

340859

Mkt Cap

162956248

Exch

NASDAQ

Country

IL

Phone

972 3 765 8585

DCF Diff

4.0991

DCF

-1.2691

Div Yield

0.0000

P/S

3.8145

EV Multiple

-33.8848

P/FV

2.7931

Div Yield %

0.0000

P/E

-17.1002

PEG

-0.3705

Payout

0.0000

Current Ratio

4.1234

Quick Ratio

4.1234

Cash Ratio

0.4795

DSO

42.7200

DIO

0.0000

Op Cycle

42.7200

DPO

153.4058

CCC

-110.6858

Gross Margin

0.8676

Op Margin

-0.1065

Pretax Margin

-0.0119

Net Margin

-0.2231

Eff Tax Rate

-17.7988

ROA

-0.0865

ROE

-0.1610

ROCE

-0.0533

NI/EBT

18.7210

EBT/EBIT

0.1119

EBIT/Rev

-0.1065

Debt Ratio

0.0041

D/E

0.0077

LT Debt/Cap

0.0000

Total Debt/Cap

0.0076

Int Coverage

0.0000

CF/Debt

0.0000

Equity Multi

1.8884

Rec Turnover

8.5440

Pay Turnover

2.3793

Inv Turnover

0.0000

FA Turnover

10.4475

Asset Turnover

0.3878

OCF/Share

0.0000

FCF/Share

0.0000

Cash/Share

1.0313

OCF/Sales

0.0000

FCF/OCF

0.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

2.7931

P/B

2.7931

P/S

3.8145

P/E

-17.1002

P/FCF

0.0000

P/OCF

0.0000

P/CF

0.0000

PEG

-0.3705

P/S

3.8145

EV Multiple

-33.8848

P/FV

2.7931

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 19, 13:34 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Benzinga Dec 19, 12:54 Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results MarketWatch Dec 19, 10:52 Compugen's stock rockets on deal with Gilead for anti-tumor drug

Revenue Product Segmentation